A Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome (CA-4948-102)
A Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome (CA-4948-102)
Trial Category:
Hematologic
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
